There were also significant effect modifications of ER status on the association between nuclear InsR and EFS where nuclear InsR+ expression in ER+ tumors was associated with a non-significant higher risk of any breast cancer event and with lower risk in patients with ER− tumors (Pinteraction = 0.003). The gene discussed is ESR1; the disease is breast cancer.